SB Pediatrics
ActiveThe computed 12-month bankruptcy probability of SB Pediatrics is 4.2% (elevated). The 2024 annual accounts show equity of €329k and a net result of €142k. Equity is growing by ~131.5% per year across the filed fiscal years. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
59
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. An elevated bankruptcy probability caps the score. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
4.2%
Elevated
0%0.5%1.5%4%10%≥ 25%
Credit up to €19k at 30 days only on tighter terms
Liquidity ample (current ratio 62.48 against 5.34 in 2023; short-term debt: 1.6% and cash: 82.3% of total assets), and 1.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
98.4%
Return on assets
42.6%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-08-2025, 4 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filingsDeviation from the deadline
2025
not confirmed
2024
4 d late
2023
29 d early
2022
28 d early
2021
9 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€329k▲ 76.5%
2023 · €186k
2021: €27k
2022: €60k
2023: €186k
2021 → 2024
Total assets
€334k▲ 46.2%
2023 · €228k
2021: €41k
2022: €90k
2023: €228k
2021 → 2024
Net result
€142k▲ 12.1%
2023 · €127k
2021: €25k
2022: €33k
2023: €127k
2021 → 2024
Working capital
€326k▲ 77.8%
2023 · €183k
2021: €27k
2022: €60k
2023: €183k
2021 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2021202220232024Trend
Equity€27k-€60k▲ 119%€186k▲ 210%€329k▲ 76.5%
Operating result€35k-€46k▲ 32.9%€165k▲ 256%€187k▲ 13.1%
Net result€25k-€33k▲ 33.1%€127k▲ 279%€142k▲ 12.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen three years in a row; 2024 is 13% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €334k
Fixed assets
€3k▼ 0.3%
Current assets
€331k▲ 46.8%
Equity and liabilities €334k
Equity
€329k▲ 76.5%
Debt
€5k▼ 87.5%
The debt ratio falls from 18.5% to 1.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€188k▲
2023 · €166k
Cash flow
€144k▲
2023 · €128k
Solvency
98.4%▲
2023 · 81.5%
Current ratio
62.48▲
2023 · 5.34
Quick ratio
62.48▲
2023 · 5.34
Debt / equity
0.02▼
2023 · 0.23
ROE
43.3%▼
2023 · 68.2%
ROA
42.6%▼
2023 · 55.6%
Interest coverage
483.27▼
2023 · 604.96
Debt
€5k▼
2023 · €42k
Debt ≤ 1 year
€5k▼
2023 · €42k
Income taxes
€44k▲
2023 · €38k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€228k€334k▲
Fixed assets21/28€3k€3k▼
Tangible fixed assets22/27€3k€3k▼
Plant, machinery and equipment23-€766
Furniture and vehicles24€3k€2k▼
Current assets29/58€225k€331k▲
Amounts receivable within one year40/41€2k€46k▲
Trade receivables40€2k€46k▲
Current investments50/53-€10k
Cash at bank and in hand54/58€195k€275k▲
Deferred charges and accrued income490/1€28k-
Equity and liabilities
Total equity and liabilities10/49€228k€334k▲
Equity10/15€186k€329k▲
Contributions10/11€3k€3k=
Reserves13€57k€57k=
Distributable reserves133€57k€57k=
Profit (loss) carried forward14€126k€269k▲
Amounts payable17/49€42k€5k▼
Amounts payable within one year42/48€42k€5k▼
Trade debts44€2k€4k▲
Suppliers440/4€2k€4k▲
Taxes, remuneration and social security45€37k€32▼
Taxes450/3€37k€32▼
Other amounts payable47/48€3k€2k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€749€1k▲
Other operating charges640/8€1k€584▼
Gross operating margin9900€167k€189k▲
Operating profit (loss)9901€165k€187k▲
Financial charges65/66B€274€389▲
Recurring financial charges65€274€389▲
Profit (loss) for the period before taxes9903€165k€186k▲
Income taxes67/77€38k€44k▲
Profit (loss) for the period9904€127k€142k▲
Profit (loss) for the period to be appropriated9905€127k€142k▲
Appropriation of the result
Profit (loss) to be appropriated9906€127k€269k▲
Profit (loss) brought forward from the previous period14P-€126k
Profit to be distributed694/7€833-
Return on contributions (dividend)694€833-
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
04-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 4 days late
2024
31-12
Financial
Highest result since 2021net €142k ▲12.1%
Operating result €187k, net result €142k, both a record.
31-12
Financial
Liquidity times 12current ratio 62.48
Current ratio from 5.34 to 62.48; short-term debt falls from €42k to €5k.
31-12
Financial
Equity above €200kEq €329k ▲76.5%
4 profitable years in a row build equity to €329k.
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €150kEq €186k ▲210%
3 profitable years in a row build equity to €186k.
03-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
09-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 9 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
René Berrewaertslaan 201070 AnderlechtGround area
314 m²
Building footprint
246 m²
Volume, LiDAR
2,249 m³
2 parcels, Brussels · tallest building 12.5 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
SB PEDIATRICS
since 20202.310.248.010
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21302A0042/00R000 | Brussels | 178 m² | 1 · 173 m² | 11.4 m · 3 fl. |
| 21003A0177/00L014 | Brussels | 136 m² | 1 · 73 m² | 12.5 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
984500B9CF94F1F38481
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded03-12-2020
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.